# Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-and-immunological-outcomes-of-high-and-low-dose-rituximab-treatments-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amrinder J. Kanwar,Keshavamurthy Vinay,Gitesh U. Sawatkar,Sunil Dogra,Ranjana W. Minz,Neil H. Shear,Hiroshi Koga,Norito Ishii,Takashi Hashimoto |
| Citations | 105 |
| DOI | 10.1111/bjd.12972 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2039443641 |
| PMID | 24640990 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Keshavamurthy Vinay](https://scholariq.org/researchers/keshavamurthy-vinay/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Paper topics

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.